ASRT vs PTC · rev $125.0M vs P/E 48, rev $2.74B
Assertio Therapeutics Inc (ASRT) versus PTC Inc (PTC) — a side-by-side from cached financials, not a winner call.
Assertio Therapeutics Inc (ASRT) is a drug manufacturers - specialty & generic company listed on US.
PTC Inc (PTC) is a software - application company listed on US.
Latest reported ASRT revenue for 2024-12-31 was $125.0M. Net income was -$21.6M. Revenue was down 17.8% from 2023-12-31 to 2024-12-31. ASRT currently screens at market cap $151.5M.
Latest reported PTC revenue for 2025-09-30 was $2.74B. Net income was $734.0M. Revenue was up 19.2% from 2024-09-30 to 2025-09-30. PTC currently screens at market cap $21.11B and trailing P/E 48.3.
ASRT currently screens at market cap $151.5M. PTC currently screens at market cap $21.11B and trailing P/E 48.3.
Not investment advice. Open the ASRT and PTC stock pages for the full models.
Not investment advice.